The Ministry of Health of Zimbabwe has approved Amatheon Agri’s license to produce cannabis for medical and scientific use. The company now embarks on an assessment and planning phase for growing and producing an assortment of cannabidiol (CBD) products The global medical cannabis industry was estimated to be worth around US$21 billion in 2020, with very high estimated annual growth rates over the next five years as an increasing number of countries approve its use. Amatheon Agri’s subsidiary in Zimbabwe was established in 2014 and seeks a first-mover advantage as the country reengages with the international community and promotes agricultural investment This extremely high-value crop supports. Amatheon Agri’s strategic expansion into export markets and diversified offerings to achieve additional contribution margins. Amatheon Agri Holding announced that its subsidiary, Amatheon Agri Zimbabwe (PVT) Ltd., has secured a license to produce medical cannabis in Zimbabwe.

Sean Hocking, Cannabis Law Report, 06/18/2021 21:24:00

Open article: